CoChat
Sign Up
Cited by 87Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsDiet, Metabolism, and Disease

Diet and nutrition in polycystic ovary syndrome (PCOS): Pointers for nutritional management

Farshchi, H., Rane, A., Love, A., Kennedy, R. L.·2007·Journal of Obstetrics and Gynaecology
DOI 10.1080/01443610701667338
Open this paper in CoChat — free account

Abstract

PCOS patients are not always markedly overweight but PCOS is strongly associated with abdominal obesity and insulin resistance. Effective approaches to nutrition and exercise improve endocrine features, reproductive function and cardiometabolic risk profile--even without marked weight loss. Recent studies allow us to make recommendations on macronutrient intake. Fat should be restricted to < or =30% of total calories with a low proportion of saturated fat. High intake of low GI carbohydrate contributes to dyslipidaemia and weight gain and also stimulates hunger and carbohydrate craving. Diet and exercise need to be tailored to the individual's needs and preferences. Calorie intake should be distributed between several meals per day with low intake from snacks and drinks. Use of drugs to either improve insulin sensitivity or to promote weight loss are justified as a short-term measure, and are most likely to be beneficial when used early in combination with diet and exercise.

Integrity signals

Registry

Crossref · 10.1080/01443610701667338

Cites

125 of 125 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Serum insulin decreased from 12.62 ± 0.48 μU/mL to 11.31 ± 0.60 μU/mL (p < 0.001).

    “Glucose decreased from 5.10 ± 0.25 mmol/L to 4.64 ± 0.24 mmol/L (p < 0.001), serum insulin from 12.62 ± 0.48 μU/mL to 11.31 ± 0.60 μU/mL (p < 0.001), and consequently HOMA-IR from 2.85 ± 0.15 to 2.32 ± 0.13 (p < 0.001) [17].”

    From Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS) (2023) · cites this paper as [17]

  • HOMA-IR decreased from 2.85 ± 0.15 to 2.32 ± 0.13 (p < 0.001).

    “Glucose decreased from 5.10 ± 0.25 mmol/L to 4.64 ± 0.24 mmol/L (p < 0.001), serum insulin from 12.62 ± 0.48 μU/mL to 11.31 ± 0.60 μU/mL (p < 0.001), and consequently HOMA-IR from 2.85 ± 0.15 to 2.32 ± 0.13 (p < 0.001) [17].”

    From Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS) (2023) · cites this paper as [17]

  • Glucose decreased from 5.10 ± 0.25 mmol/L to 4.64 ± 0.24 mmol/L (p < 0.001).

    “Glucose decreased from 5.10 ± 0.25 mmol/L to 4.64 ± 0.24 mmol/L (p < 0.001), serum insulin from 12.62 ± 0.48 μU/mL to 11.31 ± 0.60 μU/mL (p < 0.001), and consequently HOMA-IR from 2.85 ± 0.15 to 2.32 ± 0.13 (p < 0.001) [17].”

    From Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS) (2023) · cites this paper as [17]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Farshchi, H., Rane, A., Love, A., & Kennedy, R. L.
Affiliations
James Cook University (AU)
Corresponding author
Kennedy, R. L.
ORCID
Farshchi, H.
Venue
Journal of Obstetrics and Gynaecology
Publisher
Informa UK Limited
Published
2007-01
Volume
27
Issue
8
Pages
762-773
ISSN
  • 0144-3615 (ISSN-L)
  • 1364-6893
DOI
10.1080/01443610701667338
OpenAlex
W2154859309
Semantic Scholar
55365b8b0ee9c2f210fdf0992526945d5faa0c11
Cited by
87
References
125
Citations by year
2026: 1 · 2025: 9 · 2024: 12 · 2023: 7 · 2022: 12 · 2021: 11 · 2020: 8 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 1 · 2013: 4 · 2012: 3
FWCI
0.26
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Obstetrics and Gynaecology (publishedVersion)
  • PubMed (publishedVersion)
  • ResearchOnline at James Cook University (James Cook University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
polycystic ovary syndrome, nutrition, dietary management, macronutrient intake, abdominal obesity, insulin resistance, saturated fat, dyslipidemia, meal distribution, physical activity, weight loss, insulin sensitizers, cardiometabolic risk, reproductive function
MeSH terms
Diet, Dietary Carbohydrates, Dietary Fats, Dietary Proteins, Exercise Therapy, Female, Humans, Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Weight Loss, Nutrition Assessment, Body Mass Index, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review